Peptide-enhanced oral delivery of therapeutic peptides and proteins

Journal of Drug Delivery Science and Technology

Volumn 23, Issue 4, 2013, Pages 365-373

  Kristensen, M ^a   Foged, C ^a   Berthelsen, J ^a   Morck Nielsen H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cell penetrating peptide; Epithelial permeability; Intestinal barrier; Oral delivery; Peptide excipient; Therapeutic peptides and proteins; Tight junction modulating peptide

Indexed keywords

AT 1002; CARRIER PROTEINS AND BINDING PROTEINS; CELL PENETRATING PEPTIDE; CLOSTRIDIUM PERFRINGENS ENTEROTOXIN; DRUG VEHICLE; PENETRATIN; SHUFFLE PROTEIN; TIGHT JUNCTION MODULATING PEPTIDE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; ZONULA OCCLUDENS TOXIN;

CELL MEMBRANE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG STABILITY; ENDOCYTOSIS; ENZYME STABILITY; EPITHELIUM CELL; GASTROINTESTINAL TRACT; INTESTINE EPITHELIUM; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SYSTEMIC THERAPY; TIGHT JUNCTION; TRANSCYTOSIS;

EID: 84881565045     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(13)50053-0     Document Type: Review

References (92)

1. Hamman J. H., Enslin G. M., Kotze A. F. - Oral delivery of peptide drugs: barriers and developments. - BioDrugs, 19, 165-177, 2005. (Pubitemid 40994232)
2. Colombo P., Sonvico F., Colombo G., Bettini R. - Novel platforms for oral drug delivery. - Pharm. Res., 26, 601-611, 2009.
3. Song K.-H., Fasano A., Eddlngton N. D. - Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. - Int. J. Pharm., 351, 8-14, 2008. (Pubitemid 351193100)
4. Kamei N., Morishita M., Eda Y., Ida N., Nishlo R., Takayama K. - Usefulness of cell-penetrating peptides to improve intestinal insulin absorption. - J. Control. Release, 132, 21-25, 2008.
5. Frankel A., Pabo C. - Cellular uptake of the tat protein from human immunodeficiency virus. - Cell, 55, 1189-1193, 1988. (Pubitemid 19020071)
6. Derossl D., Calvet S., Trembleau A., Brunlssen A., Chassalng G., Prochiantz A. - Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. - J. Biol. Chem., 271, 18188-18193, 1996. (Pubitemid 26250811)
7. Khafagy E.-S., Morishita M., Ida N., Nishio R., Isowa K., Takayama K. - Structural requirements of penetratin absorption enhancement efficiency for Insulin delivery. - J. Control. Release, 143, 302-310, 2010.
8. Mitchell D. J., Kim D. T., Steinman L., Fathman C. G., Rothbard J. B. - Polyarginine enters cells more efficiently than other polycationic homopolymers. - J. Peptide Res., 56, 318-325, 2000.
9. Lundberg P., Langel Ü. - A brief introduction to cell-penetrating peptides. - J. Mol. Recognit., 16, 227-233, 2003. (Pubitemid 37231690)
10. Madani F., Lindberg S., Langel Ü., Futaki S., Gräslund A. - Mechanisms of cellular uptake of cell-penetrating peptides. - J. Biophys., 2011, 1-10, 2011.
11. Bellet-Amalric E., Blaudez D., Desbat B., Graner F., Gauthier F., Renault A. - Interaction of the third helix of Antennapedia homeodomain and a phospholipid monolayer, studied by ellipsometry and PM-IRRAS at the air-water interface. - Biochem. Biophys. Acta, 146, 131-143, 2000. (Pubitemid 30621592)
12. El-Andaloussi S., Holm T., Langel Ü. - Cell-penetrating peptides: mechanisms and applications. - Curr. Pharm. Design, 11, 3597-3611, 2005. (Pubitemid 41630987)
13. Bechara C., Pallerla M., Zaltsman Y., Burlina F., Alves I. D., Lequin O., Sagan S. - Tryptophan within basic peptide sequences triggersglycosaminoglycan- dependent endocytosis. - Biochem., 27, 738-749, 2013.
14. Lundin P., Johansson H., Guterstam P., Holm T., Hansen M., Langel Ü., El Andaloussi S. - Distinct uptake routes of cellpenetrating peptide conjugates. - Bioconj. Chem., 19, 2535-42, 2008.
15. Madani F., Lindberg S., Langel Ü., Futaki S., Gräslund A. - Mechanisms of cellular uptake of cell-penetrating peptides. - J. Biophys., 2011, 1-10, 2011.
16. Bäräny-Wallje E., Gaur J., Lundberg P., Langel Ü., Gräslund A. - Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo. - Fed. Eur. Biochem. Soc. Letters, 581, 2389-2393, 2007. (Pubitemid 46764694)
17. Tünnemann G., Martin R. M., Haupt S., Patsch C., Edenhofer F., Cardoso M. C. - Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. - Fed. Am. Soc. Exp. Biol. J., 20, 1775-1784, 2006. (Pubitemid 44933791)
18. Hirose H., Takeuchi T., Osakada H., Pujals S., Katayama S., Nakase I., Kobayashi S., Haraguchi T., Futaki S. - Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells. - Mol. Ther., 20, 1-10, 2012.
19. Zhang X., Wan L., Pooyan S., Su Y., Gardner C. R., Leibowitz M. J., Stein S., Sinko P. J. - Quantitative assessment of the cell penetrating properties of RI-Tat-9: evidence for a cell typespecific barrier at the plasma membrane of epithelial cells. - Mol. Pharm., 1, 145-55, 2004.
20. Foerg C., Ziegler U., Fernandez-Carneado J., Giralt E., Merkle HP. - Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases. - Pharm. Res., 24, 628-642, 2007. (Pubitemid 46411971)
21. Van der Walle C. F., Schmidt E. - Modulation of the intestinal tight junctions using bacterial enterotoxins. - In: Peptide and Protein Delivery, C. Van der Walle Ed., Academic Press, 2011, p. 195-219.
22. Deli M. A. - Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. - Biochem. Biophys. Acta, 1788, 892-910, 2009.
23. Hecht G., Pothoulakis C., LaMont J. T., Madara J. L. - Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. - J. Clin. Invest., 82, 1516-1524, 1988. (Pubitemid 19007753)
24. Just I., Fritz G., Aktories K., Giry M., Popoff M. R., Boquet P., Hegenbarth S., Von Eichel-Streiber C. - Clostridium difficile toxin B acts on the GTP-binding protein Rho. - J. Biol. Chem., 269, 10706-10712, 1994.
25. Takahashi A., Kondoh M., Masuyama A., Fujii M., Mizuguchi H., Horiguchi Y., Watanabe Y. - Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4. - J. Control. Release, 108, 56-62, 2005. (Pubitemid 41476674)
26. Krishnamurthy R., Manning M. C. - The stability factor: importance in formulation development. - Curr. Pharm. Biotech., 3, 361-371, 2002. (Pubitemid 35364010)
27. Schellekens H. - Bioequivalence and the immunogenicity of biopharmaceuticals. - Nat. Rev. Drug Discov., 1, 457-462, 2002. (Pubitemid 37361488)
28. Moal V. L., Servin A. L. - The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. - Clin. Microbiol. Rev., 19, 315-337, 2006.
29. Atuma C., Strugala V., Allen A., Holm L. - The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo the adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. - Am. J. Phys. Gastrointest. Liver Physiol., 280, 922-929, 2001.
30. Kim Y. S., Ho S. B. - Intestinal goblet cells and mucins in health and disease: recent insights and progress. - Curr. Gastroenterology Rep., 12, 319-330, 2010.
31. Lai S. K., Wang Y.-Y., Hanes J. - Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. - Adv. Drug Deliv. Rev., 61, 158-171, 2009.
32. Anderson J. M. - Epithelial Transport Molecular Structure of tightjunctions and their role in epithelial transport. - Physiol., 16, 126-130, 2001. (Pubitemid 33570301)
33. Sugano K., Kansy M., Artursson P., Avdeef A., Bendels S., Di L., Ecker G. F., Faller B., Fischer H., Gerebzoff G, Lennernaes H, Senner F. - Coexistence of passive and carrier-mediated processes in drug transport. - Nat. Rev. Drug Disc., 9, 597-614, 2010.
34. Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R., Brock R. - A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. - Traffic, 8, 848-866, 2007. (Pubitemid 46971632)
35. Pauletti G. M., Gangwar S., Knipp G. T., Nerurkar M. M., Okumu W., Tamura K., Siahaan T. J., Borchardt R. T. - Structural requirements for intestinal absorption of peptide drugs. - J. Control. Release, 41, 3-17, 1996. (Pubitemid 26246359)
36. Khafagy E.-S., Morishita M. - Oral biodrug delivery using cellpenetrating peptide. - Adv. Drug Deliv. Rev., 64, 531-9, 2012.
37. Liang J. F., Yang V. C. - Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency. - Biochem. Biophys. Res. Commun., 335, 734-738, 2005. (Pubitemid 41188260)
38. Kamei N., Morishita M., Kanayama Y., Hasegawa K., Nishimura M., Hayashinaka E., Wada Y., Watanabe Y., Takayama K. - Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography. - J. Control. Release, 146, 16-22, 2010.
39. Morishita M., Kamei N., Ehara J., Isowa K., Takayama K. - A novel approach using functional peptides for efficient intestinal absorption of insulin. - J. Control. Release, 118, 177-184, 2007. (Pubitemid 46329737)
40. Kamei N., Morishita M., Takayama K. - Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides. - J. Control. Release, 136, 179-186, 2009.
41. Stewart K. M., Horton K. L., Kelley S. O. - Cell-penetrating peptides as delivery vehicles for biology and medicine. - Org. Biomol. Chem., 6, 2242-2255, 2008. (Pubitemid 351863664)
42. Margus H., Padari K., Pooga M. - Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. - Mol. Therapy, 20, 525-533, 2012.
43. Morris M. C., Depollier J., Mery J., Heitz F., Divita G. - A peptide carrier for the delivery of biologically active proteins into mammalian cells. - Nat. Biotech., 19, 1173-1176, 2001. (Pubitemid 33115705)
44. Lindgren M., Rosenthal-Aizman K., Saar K., Eiríksdóttir E., Jiang Y., Sassian M., Ostlund P., Hallbrink M., Langel Ü. - Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. - Biochem. Pharm., 71, 416-425, 2006. (Pubitemid 43077076)
45. Khafagy E.-S., Morishita M., Kamei N., Eda Y., Ikeno Y., Takayama K. - Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins. - Int. J. Pharm., 381, 49-55, 2009.
46. Khafagy E.-S., Morishita M., Takayama K. - The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides. - Int. J. Pharm., 388, 209-212, 2010.
47. Ram N., Aroui S., Jaumain E., Bichraoul H., Mabrouk K., Ronjat M., Lortat-Jacob H., De Waard M. - Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine. - J. Biol. Chem., 283, 24274-24284, 2008.
48. Ziegler A., Seelig J. - Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9. - Biochem., 50, 4650-4664, 2011.
49. Kamei N., Kikuchi S., Takeda-morishita M., Terasawa Y., Yasuda A., Yamamoto S., Ida N., Nishio R., Takayama K. - Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps. - J. Pharm. Sci., 102, 469-479, 2013.
50. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. - Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. - J. Biol. Chem., 276, 5836-5840, 2001.
51. Tunnemann G., Ter-Avetisyan G., Martin G. M., Stoockl M., Hermann A. C. C. - Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. - J. Peptide Sci., 14, 469-476, 2008. (Pubitemid 351540908)
52. Fasano A., Baudry B., Pumplin D. W., Wasserman S. S., Tall B. D., Ketley J. M., Kaper J. B. - Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. - Proc. Natl. Acad. Sci. USA, 88, 5242-5246, 1991. (Pubitemid 21914720)
53. Di Pierro M., Lu R., Uzzau S., Wang W., Margaretten K., Pazzani C., Maimone F., Fasano A. - Zonula occludens toxin structurefunction analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. - J. Biol. Chem., 276, 19160-19165, 2001.
54. Fasano A., Uzzau S. - Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. - J. Clin. Invest., 99, 1158-1164, 1997. (Pubitemid 27142750)
55. Gopalakrishnan S., Pandey N., Tamiz A. P., Vere J., Carrasco R., Somerville R., Tripathi A., Ginski M., Paterson B. M., Alkan S. S. - Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. - Int. J. Pharm., 365, 121-130, 2009.
56. Sonoda N., Furuse M., Sasaki H., Yonemura S., Katahira J., Horiguchi Y., Tsukita S. - Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. - J. Cell Biol., 147, 195-204, 1999. (Pubitemid 30211807)
57. Veshnyakova A., Piontek J., Protze J., Waziri N., Heise I., Krause G. - Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins. - J. Biol. Chem., 287, 1698-1708, 2012.
58. Smedley J. G., Uzal F. A., McClane B. A. - Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. - Infect. Immun., 75, 2381-90, 2007. (Pubitemid 46744328)
59. Uchida H., Kondoh M., Hanada T., Takahashi A., Hamakubo T., Yagi K. - A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide. - Biochem. Pharm., 79, 1437-1444, 2010.
60. Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S. - Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. - J. Cell Biol., 141, 1539-1550, 1998. (Pubitemid 28309169)
61. Rennert R., Wespe C., Beck-Sickinger A. G., Neundorf I. - Developing novel hCT derived cell-penetrating peptides with improved metabolic stability. - Biochim. Biophys. Acta, 1758, 347-354, 2006.
62. Rothbard J. B., Kreider E., Van Deusen C. L., Wright L., Wylie B. L., Wender P. A. - Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. - J. Med. Chem., 45, 3612-3618, 2002. (Pubitemid 34856101)
63. Gammon S. T., Villalobos V. M., Prior J. L., Sharma V., Piwnica-Worms D. - Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake. - Bioconj. Chem., 14, 368-376, 2003. (Pubitemid 36348660)
64. Elmquist A., Langel U. - In vitro uptake and stability study of pVEC and its all-D analog. - Biol. Chem., 384, 387-393, 2003. (Pubitemid 36527645)
65. Horne W. S., Gellman S. H. - Foldamers with heterogeneous backbones. - Acc. Chem. Res., 41, 1399-1408, 2008.
66. Artursson P., Palm K., Luthman K. - Caco-2 monolayers in experimental and theoretical predictions of drug transport. - Adv. Drug Deliv. Rev., 22, 67-84, 1996. (Pubitemid 26423598)
67. Briske-anderson M. J., Finley J. W., Newman S. M. - The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. - Proc. Soc. Exp. Biol. Med., 248-257, 1997.
68. Hilgendorf C., Spahn-Langguth H., Regårdh C. G., Lipka E., Amidon G. L., Langguth P. - Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside-and outside-directed carrier-mediated transport. - J. Pharm. Sci., 89, 63-75, 2000. (Pubitemid 30080155)
69. Lesuffleur T., Barbat A., Dussaulx E., Zweibaum A. - Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting. - Cancer Res., 50, 6334-6343, 1990. (Pubitemid 20323697)
70. Zaro J. L., Shen W.-C. - Quantitative comparison of membrane transduction and endocytosis of oligopeptides. - Biochem. Biophys. Res. Commun., 307, 241-247, 2003. (Pubitemid 36818860)
71. Tyagi M., Rusnati M., Presta M., Giacca M. - Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. - J. Biol. Chem., 276, 3254-3261, 2001.
72. Doherty GJ, McMahon HT. - Mechanisms of endocytosis. - Ann. Rev. Biochem., 78, 857-902, 2009.
73. Conner S. D., Schmid S. L. - Regulated portals of entry into the cell. - Nature, 422, 37-44, 2003. (Pubitemid 36323287)
74. Plapied L., Duhem N., Des RieuxA., Préat V. - Fate of polymeric nanocarriers for oral drug delivery. - Curr. Opin. Colloid Interface Sci., 16, 228-237, 2011.
75. Richard J. P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M. J., Chernomordik L. V., Lebleu B. - Cell-penetrating peptides. A réévaluation of the mechanism of cellular uptake. - J. Biol. Chem., 278, 585-590, 2003. (Pubitemid 36043612)
76. Futaki S., Nakase I., Tadokoro A., Takeuchi T., Jones A. T. - Arginine-rich peptides and their internalization mechanisms. - Biochem. Soc. Transact., 35, 784-787, 2007. (Pubitemid 47310368)
77. Khalil I. A., Kogure K., Futaki S., Harashima H. - High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. - J. Biol. Chem., 281, 3544-51, 2006. (Pubitemid 43845971)
78. Fittipaldi A., Ferrari A., Zoppé M., Arcangeli C., Pellegrini V., Beltram F., Giacca M. - Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. - J. Biol. Chem., 278, 34141-34149, 2003. (Pubitemid 37553255)
79. Richard J. P., Melikov K., Brooks H., Prevot P., Lebleu B., Chernomordik L. V. - Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. - J. Biol. Chem., 280, 15300-15306, 2005. (Pubitemid 40562886)
80. Clayton A. H. A., Atcliffe B. W., Howlett G. J., Sawyer W. H. - Conformation and orientation of penetratin in phospholipid membranes. - J. Peptide Sci., 12, 233-238, 2006. (Pubitemid 43349365)
81. Christiaens B., Grooten J., Reusens M., Joliot A., Goethals M., Vandekerckhove J., Prochiantz A., Rosseneu M. - Membrane interaction and cellular internalization of penetratin peptides. - Eur. J. Biochem., 271, 1187-1197, 2004. (Pubitemid 38373051)
82. Sakai N., Takeuchi T., Futaki S., Matile S. - Direct observation of anion-mediated translocation of fluorescent oligoarginine carriers into and across bulk liquid and anionic bilayer membranes. - Chembiochem., 6, 114-122, 2005. (Pubitemid 40128644)
83. Luzio J. P., Pryor P.R., Bright N. A. - Lysosomes: fusion and function. - Nat. Rev. Mol. Cell Biol., 8, 622-632, 2007. (Pubitemid 47106614)
84. Tuma P. L., Hubbard A. L. - Transcytosis: crossing cellular barriers. - Physiol. Rev., 83, 871-932, 2003. (Pubitemid 36833216)
85. Richard J. F., Mainguy G., Gibert M., Marvaud J. C., Stiles B. G., Popoff M. R. - Transcytosis of iota-toxin across polarized CaCo-2 cells. - Mol. Microbiol., 43, 907-917, 2002. (Pubitemid 34415715)
86. Ahsan C. R., Hajnóczky, G., Maksymowych A. B., Simpson L. L. - Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells. - J. Pharm. Exp. Ther., 315, 1028-1035, 2005. (Pubitemid 41635388)
87. Chiba H., Osanai M., Murata M., Kojima T., Sawada N. - Transmembrane proteins of tight junctions. - Biochim. Biophys. Acta, 1778, 588-600, 2008. (Pubitemid 351317799)
88. Gow A., Southwood C. M., Li J. S., Pariali M., Riordan G. P., Brodie S. E., Danias J., Bronstein J. M., Kachar B., Lazzarini R. A. - CNS myelin and sertoli cell tight junction strands are absent in Osp/Claudin-11 Null Mice. - Cell, 99, 649-659, 1999. (Pubitemid 30004640)
89. Rehder D., Iden S., Nasdala I., Wegener J., Zu M. M., Vestweber D., Ebnet K. - Junctional adhesion molecule-A participates in the formation of apico-basal polarity through different domains. - Exp. Cell Res., 312, 3389-3403, 2006. (Pubitemid 44380238)
90. Saitou M., Furuse M., Sasaki H., Fromm M., Takano H., Noda T., Tsukita S., Franklin B., Universita F. - Complex phenotype of mice lacking occludin, a component of tight Junction strands. - Mol. Biol. Cell, 11, 4131-4142, 2000.
91. Krause G., Winkler L., Mueller S. L., Haseloff R. F., Piontek J., Blasig I. E. - Structure and function of claudins. - Biochim. Biophys. Acta, 1778, 631-645, 2008.
92. Fasano A., Fiorentini C., Donelli G., Uzzau S., Kaper J. B., Margaretten K., Ding X., Guandalini S., Comstock L., Goldblum S. E. - Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. - J. Clin. Invest., 96, 710-720, 1995.